RUXIENCE 10 MG/ML SOL DIL INFUS IV CT FA VD TRANS X 10 ML

Presentation · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brazil

  • Registration number 1211004780012
  • GGREM 522720090089607
  • Barcode 7891045033152

What the source publishes

Holder
PFIZER BRASIL LTDA
Active ingredients
RITUXIMABE
Package
10 MG/ML SOL DIL INFUS IV CT FA VD TRANS X 10 ML
Supply regime
Tarja Vermelha
Product type
Biológico
Therapeutic class
L1G1 - ANTICORPOS MONOCLONAIS ANTINEOPLÁSICOS, CD20
Prescription
Prescription or restricted

Names this record is found by

Complete source data
br:cmed:presentations:522720090089607
{
  "name": "RUXIENCE 10 MG/ML SOL DIL INFUS IV CT FA VD TRANS X 10 ML",
  "holder": "PFIZER BRASIL LTDA",
  "stripe": "Tarja Vermelha",
  "barcodes": [
    "7891045033152"
  ],
  "confaz87": false,
  "currency": "BRL",
  "marketed": null,
  "ggremCode": "522720090089607",
  "useDomain": "unknown",
  "capApplies": null,
  "icmsExempt": true,
  "holderTaxId": "61.072.393/0001-33",
  "priceRegime": "Regulado",
  "productName": "RUXIENCE",
  "productType": "Biológico",
  "hospitalOnly": true,
  "presentation": "10 MG/ML SOL DIL INFUS IV CT FA VD TRANS X 10 ML",
  "sourceStatus": null,
  "supplyRegime": "Tarja Vermelha",
  "factoryPrices": {
    "icms-0": "1206.33",
    "icms-12": "1370.83",
    "icms-17": "1453.41",
    "icms-18": "1471.13",
    "icms-19": "1489.30",
    "icms-20": "1507.91",
    "icms-21": "1527.00",
    "icms-22": "1546.58",
    "icms-23": "1566.66",
    "icms-17.5": "1462.22",
    "icms-19.5": "1498.55",
    "icms-20.5": "1517.40",
    "icms-22.5": "1556.56",
    "icms-12-alc": "1354.38",
    "icms-17-alc": "1435.97",
    "icms-18-alc": "1453.48",
    "icms-19-alc": "1471.42",
    "icms-20-alc": "1489.82",
    "icms-21-alc": "1508.68",
    "icms-22-alc": "1528.02",
    "icms-23-alc": "1547.86",
    "withoutTaxes": "1191.85",
    "icms-17.5-alc": "1444.67",
    "icms-19.5-alc": "1480.56",
    "icms-20.5-alc": "1499.19",
    "icms-22.5-alc": "1537.88"
  },
  "pisCofinsList": "Positiva",
  "substanceText": "RITUXIMABE",
  "targetSpecies": [],
  "consumerPrices": null,
  "invalidBarcodes": [],
  "activeSubstances": [
    "RITUXIMABE"
  ],
  "therapeuticClass": "L1G1 - ANTICORPOS MONOCLONAIS ANTINEOPLÁSICOS, CD20",
  "commercialisation": {
    "year": 2025,
    "marketed": true
  },
  "priceAnalysisNote": null,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "br.anvisa.cmed-prices"
  },
  "patientEligibility": "not-assessed",
  "registrationNumber": "1211004780012",
  "targetSpeciesStatus": "not-reported",
  "administrativeStatus": "unknown",
  "prescriptionCategory": "prescription-or-restricted",
  "prescriptionRequired": true,
  "therapeuticClassCode": "L1G1",
  "commercialDestination": null,
  "registrationNumberFlag": null
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=br" \
  --data-urlencode "sourceId=br.anvisa.cmed-prices" \
  --data-urlencode "id=br:cmed:presentations:522720090089607"